Fingerprint
Dive into the research topics of 'Tofacitinib in patients with ankylosing spondylitis: A phase II, 16-week, randomised, placebo-controlled, dose-ranging study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Tofacitinib in patients with ankylosing spondylitis: A phase II, 16-week, randomised, placebo-controlled, dose-ranging study
Désirée Van Der Heijde, Atul Deodhar, James C. Wei, Edit Drescher, Dona Fleishaker, Thijs Hendrikx, David Li, Sujatha Menon, Keith S. Kanik
Research output: Contribution to journal › Article › peer-review
256
Scopus
citations